CLINICAL_TRIALS
trial_result
· 2022-06-22
Clinical Trial Update: Thymol on Netrin-1 on Obese Patients [Phase 2]
Summary
Phase 2 trial update investigating thymol's effect on Netrin-1 in obese patients with inflammatory response.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centro Universitario de Ciencias de la Salud, Mexico | Conditions: Inflammatory Response, Obesity | Phase 2 | Status: UNKNOWN